Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Average Rating of 'Strong Buy' by Analysts
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) has received an average rating of 'Strong Buy' from the eight research firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a…
JB Pharma net profit jumps 22% on strong domestic, global momentum
Driven by momentum at home and in international markets, the consolidated net profit of JB Chemicals & Pharmaceuticals Ltd (JB Pharma) rose by 22.2 percent year-on-year to ₹198 crore during the third quarter of the current financial year FY…
Royalty Pharma (NASDAQ:RPRX) Raised to 'Strong-Buy' at Wall Street Zen
Royalty Pharma (NASDAQ:RPRX - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'buy' rating to a 'strong-buy' rating in a report released on Saturday. How Royalty Pharma Prints Cash Without Biotech's Biggest Risks A…
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Update
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 368 shares, a growth…
Campbell & CO Investment Adviser LLC Invests $2.39 Million in Ascendis Pharma A/S $ASND
Campbell & CO Investment Adviser LLC acquired a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor…
BridgeBio Pharma (NASDAQ:BBIO) Sees Large Volume Increase - Still a Buy?
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) saw unusually-high trading volume on Friday. Approximately 3,621,276 shares traded hands during mid-day trading, an increase of 15% from the previous session's volume of 3,159,396 shares.The…
Sumitomo Mitsui Trust Group Inc. Buys 207,338 Shares of Royalty Pharma PLC $RPRX
Sumitomo Mitsui Trust Group Inc. raised its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 23.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,101,641…
Five Takeaways From The 2026 J.P. Morgan Healthcare Conference
The author Juergen Eckhardt, pictured center, speaking this week at a panel on medical innovation hosted by the WuXi Global Forum, at the JP Morgan Healthcare Conference. This week, I had the pleasure of attending the annual J.P. Morgan Conference…
DFW Capital, GPP, SK Capital eye pharma commercialization; Chicago Bears QB Caleb Williams' 888 Midas gears up for future investment plays
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Sun Pharma launches skin cancer medication in US
What's the story Sun Pharmaceutical Industries has launched its skin cancer drug, Unloxcyt (cosibelimab-ipdl), in the US. The Mumbai-based company announced that the drug is now available for prescription by healthcare professionals. It is intended…
We must be alert to marketers' attempts to cash in on conditions like autism
Kelly Given (Jan 15) rightly identifies as yet another stereotype, this time a female autistic person to come alongside the male “Rain Man” cliche so pervasive and so unrepresentative of the neurodivergence and neurodiversity of human…
Trump's New Prescription Plan vs. Mark Cuban's: Experts Weigh In
CREDIT: Trump: Shawn Thew - Pool via CNP; Cuban: Ron Sachs/CNP / iStock.com GOBankingRates' editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services -…
A pair of transitions at the top and more leadership moves across the market
Thomson Reuters Special Services Dana Barnes has joined this subsidiary of the global financial data giant as president to lead the next phase of its strategy in the national security market. The two-decade federal market veteran most recently…
Udit Misra writes: India must widen, and deepen, its export pool to offset Trump's tariffs
India exported goods worth $38.5 billion in December 2025, a modest 1.8% increase over the $37.8-billion export figure recorded in December 2024, according to data shared by the Ministry of Commerce and Industry on Thursday. In December, India…
Bruce Broussard on leaving Humana, reputational risks of AI
This is a preview of the January 15 edition of Access Health— Tap here to get this newsletter delivered straight to your inbox on Thursday mornings. We had both rain and snow in Chicago yesterday, so I'm jealous of that 60-degree weather you…
Receive a Daily briefing on Pharma Industry News
Get Started